thumbnail
Facilities & CapacityPfizer abandons $350m+ Seattle plant post-Seagen acquisitionPfizer abandons $350m+ Seattle plant post-Seagen acquisition
Pfizer will end construction and exit a 270,000 square-foot facility in Everett, Washington as it realigns its network following the $43 billion acquisition of Seagen.